Disease Modifying Genes in Severe Asthma

NCT00212537 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 941

Last updated 2022-08-30

No results posted yet for this study

Summary

Gene and protein bank to study disease modifying and susceptibility genes and proteins in urban patients with asthma.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Joan Reibman, MD · NYU School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-04-08
Primary Completion
2011-01-13
Completion
2019-07-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00212537 on ClinicalTrials.gov